ARTICLE | Management Tracks
Germano succeeds Starr as Sage chair
Plus: CEO changes at Xoma, Affimed, and updates from ArriVent, Calliditas, Prime, Caribou, Janux and Insitro
January 9, 2024 2:07 AM UTC
Geno Germano became chair at Sage Therapeutics Inc. (NASDAQ:SAGE), succeeding Kevin Starr, who is retiring after serving in the role for a decade. Germano is president and CEO of Elucida Oncology Inc., and has served on Sage’s board since 2016.
Former Sage CEO Jeff Jonas and CSO Al Robichaud joined Cure Ventures as partners. Jonas was most recently CEO of ABio-X, an incubation platform...